Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/14/24 16:05 | 6/12/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Colangelo Dominick | MA | DO | P,CEO | 8 | S.dm | -11,023 | 42.92 | 0 | -257 | 221 | D | |||||||||||||||
5/21/24 16:07 | 5/20/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | 2 | S.d | -682 | 45.46 | 0 | -15 | 58 | D | |||||||||||||||
3/29/24 16:05 | 3/27/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Zerbe Robert L Md | MA | D | 9 | S.d | -892 | 42.50 | 0 | -21 | 34 | D | ||||||||||||||||
3/15/24 16:05 | 3/8/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Flynn Sean C. | MA | O | SVP,GC | 3 | S.m | -789 | 44.39 | 0 | -18 | 4 | D | |||||||||||||||
3/13/24 16:05 | 3/11/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Halpin Michael | MA | O | COO | 2 | S.d | -970 | 38.30 | 0 | -25 | 1 | D | |||||||||||||||
3/11/24 16:08 | 3/7/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Siegal Jonathan | MA | O | Principa | 3 | S | -109 | 41.40 | 0 | -3 | 1 | D | |||||||||||||||
12/15/23 16:07 | 12/14/23 | VCEL | Health | BioPrd | Biological Products, (No Diag | Wotton Paul K | MA | D | 1 | S | -187 | 37.31 | 0 | -5 | 27 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |